Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 33 | 2024 | 450 | 4.660 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2013 | 25 | 0.860 |
Why?
|
| Breast Feeding | 3 | 2013 | 47 | 0.840 |
Why?
|
| Humans | 68 | 2024 | 32262 | 0.770 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 116 | 0.740 |
Why?
|
| Accidental Falls | 3 | 2017 | 104 | 0.700 |
Why?
|
| Female | 49 | 2024 | 19935 | 0.700 |
Why?
|
| Rural Population | 3 | 2024 | 216 | 0.670 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2023 | 51 | 0.670 |
Why?
|
| United Nations | 1 | 2020 | 4 | 0.620 |
Why?
|
| Anti-HIV Agents | 5 | 2024 | 64 | 0.620 |
Why?
|
| Statistics as Topic | 1 | 2020 | 99 | 0.610 |
Why?
|
| Electronic Health Records | 3 | 2017 | 179 | 0.600 |
Why?
|
| Male | 42 | 2024 | 19429 | 0.560 |
Why?
|
| Guideline Adherence | 1 | 2018 | 109 | 0.520 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2016 | 11 | 0.500 |
Why?
|
| Pharmacists | 1 | 2016 | 20 | 0.490 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 183 | 0.490 |
Why?
|
| Water Pollutants, Chemical | 1 | 2016 | 4 | 0.480 |
Why?
|
| Fluorocarbons | 1 | 2016 | 21 | 0.480 |
Why?
|
| Family Practice | 1 | 2016 | 49 | 0.480 |
Why?
|
| Internal Medicine | 1 | 2016 | 53 | 0.480 |
Why?
|
| Trauma Centers | 4 | 2017 | 84 | 0.460 |
Why?
|
| Adult | 27 | 2024 | 9252 | 0.460 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 73 | 0.460 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 335 | 0.450 |
Why?
|
| HIV-1 | 2 | 2012 | 46 | 0.450 |
Why?
|
| Simian immunodeficiency virus | 1 | 2015 | 2 | 0.440 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2015 | 2 | 0.440 |
Why?
|
| AIDS Vaccines | 1 | 2015 | 2 | 0.440 |
Why?
|
| Analgesics, Opioid | 4 | 2019 | 251 | 0.440 |
Why?
|
| Hospice Care | 1 | 2015 | 13 | 0.440 |
Why?
|
| Advance Care Planning | 1 | 2015 | 15 | 0.430 |
Why?
|
| Terminal Care | 1 | 2015 | 25 | 0.430 |
Why?
|
| Physicians | 1 | 2016 | 163 | 0.430 |
Why?
|
| Primates | 1 | 2015 | 128 | 0.420 |
Why?
|
| Smoking | 4 | 2021 | 505 | 0.410 |
Why?
|
| Smoking Cessation | 3 | 2021 | 211 | 0.410 |
Why?
|
| Chlamydia Infections | 3 | 2022 | 9 | 0.400 |
Why?
|
| Vaginosis, Bacterial | 2 | 2024 | 7 | 0.400 |
Why?
|
| Gonorrhea | 3 | 2022 | 12 | 0.400 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 390 | 0.380 |
Why?
|
| Prevalence | 7 | 2022 | 955 | 0.380 |
Why?
|
| Aged | 16 | 2023 | 10249 | 0.380 |
Why?
|
| Middle Aged | 23 | 2024 | 11837 | 0.380 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 544 | 0.380 |
Why?
|
| Renal Dialysis | 1 | 2015 | 275 | 0.370 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 763 | 0.360 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2021 | 18 | 0.350 |
Why?
|
| Patient Transfer | 3 | 2016 | 41 | 0.340 |
Why?
|
| United States | 12 | 2023 | 4068 | 0.340 |
Why?
|
| Risk Assessment | 6 | 2019 | 1423 | 0.320 |
Why?
|
| Alabama | 7 | 2023 | 41 | 0.320 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 3893 | 0.300 |
Why?
|
| West Virginia | 7 | 2017 | 16 | 0.300 |
Why?
|
| Patient Compliance | 2 | 2022 | 206 | 0.290 |
Why?
|
| Risk Factors | 10 | 2022 | 3933 | 0.280 |
Why?
|
| Retrospective Studies | 9 | 2023 | 3609 | 0.280 |
Why?
|
| Computer Simulation | 4 | 2023 | 251 | 0.270 |
Why?
|
| Opioid-Related Disorders | 3 | 2019 | 68 | 0.260 |
Why?
|
| Exercise | 3 | 2023 | 605 | 0.240 |
Why?
|
| Young Adult | 8 | 2024 | 2643 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 1437 | 0.230 |
Why?
|
| Syphilis | 2 | 2022 | 10 | 0.230 |
Why?
|
| Trichomonas Infections | 2 | 2021 | 2 | 0.220 |
Why?
|
| Incidence | 4 | 2022 | 1241 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2018 | 158 | 0.210 |
Why?
|
| Infant, Newborn | 4 | 2016 | 666 | 0.210 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2024 | 1 | 0.210 |
Why?
|
| Hypertension | 2 | 2022 | 980 | 0.200 |
Why?
|
| Overweight | 3 | 2024 | 252 | 0.200 |
Why?
|
| Seizures | 2 | 2022 | 65 | 0.200 |
Why?
|
| Infant | 4 | 2016 | 1010 | 0.200 |
Why?
|
| Quality of Life | 2 | 2020 | 968 | 0.200 |
Why?
|
| Health Personnel | 1 | 2024 | 112 | 0.200 |
Why?
|
| Socioeconomic Factors | 3 | 2023 | 388 | 0.200 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 140 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2023 | 16 | 0.190 |
Why?
|
| Obesity | 5 | 2024 | 1111 | 0.190 |
Why?
|
| Adolescent | 8 | 2024 | 3509 | 0.190 |
Why?
|
| Models, Statistical | 1 | 2023 | 187 | 0.190 |
Why?
|
| Hallucinogens | 1 | 2022 | 13 | 0.190 |
Why?
|
| Medication Adherence | 1 | 2024 | 160 | 0.180 |
Why?
|
| Periodontitis | 1 | 2022 | 10 | 0.180 |
Why?
|
| Cohort Studies | 6 | 2022 | 1839 | 0.180 |
Why?
|
| Adiposity | 1 | 2023 | 190 | 0.180 |
Why?
|
| Restless Legs Syndrome | 1 | 2021 | 2 | 0.180 |
Why?
|
| Parent-Child Relations | 1 | 2022 | 45 | 0.180 |
Why?
|
| Pilot Projects | 5 | 2023 | 553 | 0.170 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2021 | 55 | 0.170 |
Why?
|
| Telemedicine | 1 | 2023 | 122 | 0.170 |
Why?
|
| Antigens, Differentiation | 1 | 2021 | 27 | 0.170 |
Why?
|
| Prospective Studies | 6 | 2024 | 2315 | 0.160 |
Why?
|
| Conversion Disorder | 1 | 2020 | 2 | 0.160 |
Why?
|
| Primary Health Care | 3 | 2022 | 232 | 0.160 |
Why?
|
| Psychophysiologic Disorders | 1 | 2020 | 5 | 0.160 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 94 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 79 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2020 | 34 | 0.150 |
Why?
|
| Stress, Psychological | 2 | 2021 | 227 | 0.150 |
Why?
|
| Health Services Research | 1 | 2019 | 81 | 0.150 |
Why?
|
| Prescription Drugs | 1 | 2019 | 19 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 38 | 0.140 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 45 | 0.140 |
Why?
|
| SEER Program | 1 | 2018 | 38 | 0.140 |
Why?
|
| Minority Groups | 1 | 2018 | 81 | 0.140 |
Why?
|
| Weight Loss | 1 | 2021 | 410 | 0.140 |
Why?
|
| Nicotinic Agonists | 1 | 2018 | 39 | 0.140 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 47 | 0.140 |
Why?
|
| Living Donors | 1 | 2018 | 61 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 122 | 0.130 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 23 | 0.130 |
Why?
|
| Mothers | 2 | 2022 | 74 | 0.130 |
Why?
|
| Diet | 1 | 2020 | 383 | 0.130 |
Why?
|
| Food Preferences | 1 | 2017 | 34 | 0.130 |
Why?
|
| Viral Load | 3 | 2023 | 73 | 0.130 |
Why?
|
| Vitamin D | 1 | 2018 | 186 | 0.130 |
Why?
|
| Age Factors | 2 | 2017 | 1178 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 212 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 458 | 0.120 |
Why?
|
| Transportation of Patients | 1 | 2017 | 22 | 0.120 |
Why?
|
| Medicare | 1 | 2018 | 218 | 0.120 |
Why?
|
| Comorbidity | 4 | 2021 | 563 | 0.120 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 42 | 0.120 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 26 | 0.120 |
Why?
|
| Hospital Mortality | 2 | 2015 | 197 | 0.120 |
Why?
|
| Homosexuality, Male | 3 | 2022 | 115 | 0.120 |
Why?
|
| Sports | 1 | 2017 | 43 | 0.120 |
Why?
|
| Nicotine | 1 | 2018 | 164 | 0.120 |
Why?
|
| Ohio | 1 | 2016 | 63 | 0.120 |
Why?
|
| Hospitals, Urban | 1 | 2016 | 12 | 0.120 |
Why?
|
| Triage | 1 | 2016 | 68 | 0.120 |
Why?
|
| Hospitals, Rural | 1 | 2016 | 11 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 656 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 72 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 395 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 64 | 0.110 |
Why?
|
| Binomial Distribution | 1 | 2015 | 2 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2015 | 50 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2016 | 367 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2016 | 79 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2023 | 309 | 0.110 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 95 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 70 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2015 | 146 | 0.110 |
Why?
|
| Echocardiography | 1 | 2015 | 190 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 186 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2016 | 178 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 168 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 490 | 0.110 |
Why?
|
| Sarcolemma | 1 | 2014 | 4 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2016 | 142 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 20 | 0.110 |
Why?
|
| Mitochondria, Heart | 1 | 2014 | 17 | 0.100 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 241 | 0.100 |
Why?
|
| Malawi | 1 | 2013 | 22 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2024 | 19 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2017 | 864 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 444 | 0.100 |
Why?
|
| Vagina | 2 | 2024 | 61 | 0.100 |
Why?
|
| Stroke | 1 | 2019 | 691 | 0.100 |
Why?
|
| Peptide Nucleic Acids | 1 | 2012 | 4 | 0.100 |
Why?
|
| Candida | 1 | 2012 | 7 | 0.100 |
Why?
|
| Candidiasis | 1 | 2012 | 6 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 43 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 2012 | 44 | 0.090 |
Why?
|
| Heterosexuality | 2 | 2022 | 15 | 0.090 |
Why?
|
| Milk, Human | 1 | 2011 | 16 | 0.090 |
Why?
|
| Causality | 2 | 2021 | 37 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2021 | 93 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 1478 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1081 | 0.080 |
Why?
|
| Universities | 2 | 2023 | 149 | 0.080 |
Why?
|
| Mass Screening | 2 | 2023 | 256 | 0.080 |
Why?
|
| Students | 2 | 2023 | 174 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 534 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2024 | 863 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 759 | 0.070 |
Why?
|
| Pregnancy | 2 | 2024 | 960 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 2238 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3408 | 0.060 |
Why?
|
| Animals | 2 | 2015 | 8196 | 0.060 |
Why?
|
| Registries | 2 | 2018 | 294 | 0.060 |
Why?
|
| Logistic Models | 2 | 2019 | 743 | 0.060 |
Why?
|
| Dominican Republic | 1 | 2024 | 2 | 0.050 |
Why?
|
| Uganda | 1 | 2024 | 9 | 0.050 |
Why?
|
| Fertilization | 1 | 2024 | 5 | 0.050 |
Why?
|
| Gardnerella | 1 | 2024 | 1 | 0.050 |
Why?
|
| Microbial Interactions | 1 | 2024 | 1 | 0.050 |
Why?
|
| Prevotella | 1 | 2024 | 8 | 0.050 |
Why?
|
| Poisson Distribution | 1 | 2023 | 17 | 0.050 |
Why?
|
| Cameroon | 1 | 2023 | 4 | 0.050 |
Why?
|
| Weight Gain | 1 | 2024 | 104 | 0.050 |
Why?
|
| Child | 2 | 2022 | 2430 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 167 | 0.050 |
Why?
|
| Testosterone | 1 | 2023 | 48 | 0.050 |
Why?
|
| Stavudine | 1 | 2022 | 1 | 0.050 |
Why?
|
| Ritonavir | 1 | 2022 | 3 | 0.050 |
Why?
|
| Alkynes | 1 | 2022 | 2 | 0.050 |
Why?
|
| Integrase Inhibitors | 1 | 2022 | 1 | 0.050 |
Why?
|
| Schools | 1 | 2023 | 65 | 0.050 |
Why?
|
| Benzoxazines | 1 | 2022 | 28 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2022 | 13 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 83 | 0.050 |
Why?
|
| Food Supply | 1 | 2023 | 64 | 0.050 |
Why?
|
| Length of Stay | 2 | 2014 | 321 | 0.050 |
Why?
|
| Social Support | 1 | 2023 | 180 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2022 | 38 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2021 | 21 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 160 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 21 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 19 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 65 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 253 | 0.040 |
Why?
|
| Motor Activity | 1 | 2023 | 332 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2020 | 12 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2021 | 130 | 0.040 |
Why?
|
| Internal-External Control | 1 | 2020 | 14 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 426 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2021 | 102 | 0.040 |
Why?
|
| Safety | 1 | 2020 | 65 | 0.040 |
Why?
|
| Parents | 1 | 2022 | 151 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2020 | 30 | 0.040 |
Why?
|
| Attention | 1 | 2020 | 84 | 0.040 |
Why?
|
| Sickness Impact Profile | 1 | 2020 | 39 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 2203 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2020 | 72 | 0.040 |
Why?
|
| Self Concept | 1 | 2020 | 45 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 199 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 363 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 854 | 0.040 |
Why?
|
| Selection Bias | 1 | 2019 | 13 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2020 | 120 | 0.040 |
Why?
|
| Minority Health | 1 | 2018 | 5 | 0.040 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 38 | 0.040 |
Why?
|
| HIV | 1 | 2018 | 26 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2018 | 10 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 32 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 536 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2020 | 204 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2018 | 91 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2019 | 455 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 87 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 128 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 650 | 0.030 |
Why?
|
| Personal Autonomy | 1 | 2017 | 9 | 0.030 |
Why?
|
| Bone Density | 1 | 2018 | 169 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 83 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 356 | 0.030 |
Why?
|
| Observation | 1 | 2016 | 22 | 0.030 |
Why?
|
| Health Behavior | 1 | 2017 | 213 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2015 | 33 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 132 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 316 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2016 | 141 | 0.030 |
Why?
|
| Systole | 1 | 2015 | 94 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2017 | 339 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 98 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 305 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 204 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2016 | 184 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 183 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2014 | 20 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 880 | 0.030 |
Why?
|
| Body Height | 1 | 2014 | 34 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2014 | 110 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 484 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 1233 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2015 | 417 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 839 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 191 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 104 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 2571 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 1529 | 0.020 |
Why?
|